Cargando…
Robust aptamer–polydopamine-functionalized M-PLGA–TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy
One limitation of current biodegradable polymeric nanoparticles (NPs) is the contradiction between functional modification and maintaining formerly excellent bioproperties with simple procedures. Here, we reported a robust aptamer–polydopamine-functionalized mannitol-functionalized poly(lactide-co-g...
Autores principales: | Xu, Guojun, Yu, Xinghua, Zhang, Jinxie, Sheng, Yingchao, Liu, Gan, Tao, Wei, Mei, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922762/ https://www.ncbi.nlm.nih.gov/pubmed/27382282 http://dx.doi.org/10.2147/IJN.S103513 |
Ejemplares similares
-
Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
por: Chen, Hongbo, et al.
Publicado: (2010) -
Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles
por: Gao, Jie, et al.
Publicado: (2019) -
Polydopamine-Based Surface Modification of Novel Nanoparticle-Aptamer Bioconjugates for In Vivo Breast Cancer Targeting and Enhanced Therapeutic Effects
por: Tao, Wei, et al.
Publicado: (2016) -
Employing a PLGA-TPGS based nanoparticle to improve the ocular delivery of Acyclovir
por: Alkholief, Musaed, et al.
Publicado: (2019) -
GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells
por: Li, Kaichun, et al.
Publicado: (2021)